InvestorsHub Logo
Followers 87
Posts 6773
Boards Moderated 1
Alias Born 09/18/2009

Re: None

Monday, 07/31/2023 6:51:53 PM

Monday, July 31, 2023 6:51:53 PM

Post# of 43161
So, an ETF with a phytomedical research and biopharmaceutical drug development company?

Targeting Cytokine release syndrome, or CRS...potential to reset the body’s immune system after triggering hyperinflammation. Post-exposure target population...
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.